Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery

NCT00090025 is registered in ClinicalTrials.gov with Helsinn Healthcare SA as lead sponsor.

NCT NCT00090025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00090025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Multicenter, Open Label, Randomized Study of XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Not Amenable to Conventional Surgery
Lead sponsor
Helsinn Healthcare SA
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2004
Completion date
November 30, 2006
Enrollment
248 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer